Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1-Reference-Cited by-同舟云学术

Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1

Published:2018-04-28 Issue:12 Volume:20 Page:1643-1651
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Gross Andrea M¹,Singh Gurbani¹,Akshintala Srivandana¹,Baldwin Andrea¹,Dombi Eva¹,Ukwuani Somto¹,Goodwin Anne¹,Liewehr David J²,Steinberg Seth M²,Widemann Brigitte C¹

Affiliation:

1. Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland

2. Center for Cancer Research, National Cancer Institute (NCI) of the National Institutes of Health, Bethesda, Maryland

Funder

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/20/12/1643/26495504/noy067.pdf

Reference20 articles.

1. Optimizing biologically targeted clinical trials for neurofibromatosis;Gutmann;Expert Opin Investig Drugs,2013

2. Dissecting clinical heterogeneity in neurofibromatosis type 1;Monroe;Annu Rev Pathol,2017

3. How does the Schwann cell lineage form tumors in NF1;Carroll;Glia,2008

4. Plexiform neurofibromas;Korf;Am J Med Genet,1999

5. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1;Mautner;Neuro Oncol,2008

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating therapeutic nonsense suppression in a neurofibromatosis mouse model;Experimental Neurology;2024-10

2. Soft tissue sarcomas associated with neurofibromatosis: treatment experience;Bone and soft tissue sarcomas, tumors of the skin;2024-09-12

3. Reduced PTPRS expression promotes epithelial-mesenchymal transition of Schwann cells in NF1-related plexiform neurofibromas;Cancer Letters;2024-09

4. Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors;American Society of Clinical Oncology Educational Book;2024-06

5. Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management;Journal of Clinical Medicine;2024-03-20